Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Why we are not a bunch of happy investors is besides me.
View:
Post by cashascars on Mar 30, 2022 9:31pm

Why we are not a bunch of happy investors is besides me.

While I understand being impatient for an update from the company, if they are still waiting for pertinent information to put in it why the glum faces. We are 2 cents off the 52 week high and really more like 2 cents off the 2 1/2 year high, and this should put all of us in a positive position with our investment. Those that bought higher years ago at higher prices and are still holding likely bought more to average down so even they would be in the money. If you missed your opportunity to average down, well what can I say you missed a huge opportunity, but hope is still not over for you as this will easily go beyond all time highs by many multiples if the science proves up.

 

I'm pretty sure any big sellers here are investors who do not know the story, likely they bought into the .30 cent PP a few years ago and they see 50% on their money not including the trade able warrants that they likely sold off early on after the financing of which I bought plenty of under .10 cents in the first few days of their trading.


Now I will comment on any one who thinks negative news is on the table and this is the reason for the delay. This would be against the law to hold back releasing such news and I can not see them doing that. So the news we are waiting for is more likely positive in nature but they know they can wait while more data comes in and as long as the Data is similar to Novembers update they can hold on to it as long as they want as there is no real change to the progress of the Phase 2 except more of the same positive data over longer periods of time. 
In this case No News is good news so far. Negative would need to have been released or needs to be released in a timely manner so no one can profit by the information.


Long Strong and happy but yes anxious for the GOOD news to be released.


Cashascars

Comment by ScienceFirst on Mar 30, 2022 10:08pm
Great post Cashascars.  Extremely well stated. The more they wait, the more they can say we have x more patients treated.  Each patient added between the expected 3-month newsletter awaited Feb. 29 and today (one month later) could help us say we're now at y patients overall.  And when comes the next round of data (July), we will be able to report on those x patients that ...more  
Comment by gossamer9 on Mar 30, 2022 10:42pm
This post has been removed in accordance with Community Policy
Comment by menoalittle on Mar 30, 2022 11:47pm
>> If you missed your opportunity to average down... In retrospect, the "opportunity to average down" (my gosh... what a polite way to phrase the last 2 and a half years here... lol) has probably resulted in my position here being a good 10 times (or more) larger than I would have ever imagined in my wildest (or craziest) dreams.  Not completely sure yet whether them' ...more  
Comment by Lesalpes29 on Mar 31, 2022 7:24am
A lot of good positive posts and vibes. Back to waiting patiently for the results.
Comment by Eoganacht on Mar 31, 2022 11:57am
Well put cashascars. The prospects for Theralase investors has never been better.  And once Theralase gets approval for it's NMIBC treatment, there will be the possibility of eventual off-label use for other forms of cancer. And there is a whole world of innovative research waiting to be verified and implemented. X-ray activation of systemically administered rutherrin for gbm and nsclc ...more  
Comment by enriquesuave on Mar 31, 2022 1:34pm
MIBC might be another indication making them own the Bladder Cancer market in its entirety as a possibility.  IMO. Animal studies have shown a 100% Tumor destruction in MIBC as well with same procedure. 
Comment by ScienceFirst on Mar 31, 2022 2:57pm
Yep!  In 2015, TLT made the demonstration.  Of course, MIBC representing only 30% of the cases, TLT started with NMIBC (70%), the biggest market. https://theralase.com/theralase-research-demonstrates-lead-drug-also-effective-for-muscle-invasive-bladder-cancer/
Comment by floatinketucky on Apr 01, 2022 7:23am
Results (Representative of Human Low Dose): – Five tumours treated with 0.6 mgmL-1 TLD-1433 (representative of human low dose) followed by PDT showed a strong response to the PDT with complete destruction of the tumour, with large areas of hemorrhage, necrosis (cell kill), and inflammation present throughout the whole depth of the tumour. Karate... Mighty blow... YEP that was ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250